March 1, 2018
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Illinois from January 2017 through December 2017.…
March 1, 2018
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Georgia from January 2017 through December 2017.…
March 1, 2018
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Arkansas from January 2017 through December 2017.…
February 26, 2018
Waiting is a fact of life for patients with rare diseases such as cystic fibrosis.
Many of these men and women, whose disease causes wheezing and frequent lung infections, live waiting for new and effective medications. They have to delay activities due to symptoms that make breathing a struggle. They wait for treatment, fighting through health plan barriers such as prior authorization or awaiting the decision of opaque bureaucracies such as Medicaid pharmacy and therapeutics committees.
February 22, 2018
Patients covered by Medicaid in Kentucky and Indiana could soon find themselves in a difficult position. According to new rules, recipients must complete 80 hours of “community engagement” or risk losing their health coverage.
February 20, 2018
It might be itching, chills, fatigue or sleeplessness. Side effects are common with prescription drugs. So how do regulators, patients and physicians keep tabs on these events and ensure that drugs are safe in everyday use?
February 18, 2018
Under Medicare’s 2007 Physician Quality Reporting Initiative (PQRI), eligible professionals who successfully report a designated set of quality measures on…
February 16, 2018
In a Tuesday policy panel sponsored by The Headache and Migraine Policy Forum, experts from across the health care and veterans support spectrum weighed in on how migraine and headache disorders impact veterans – and whether these women and men can access the treatment they need.
February 15, 2018
The Food and Drug Administration approved a new drug that helps address the underlying cause of cystic fibrosis, not simply its symptoms. The drug, a combination of tezacaftor/ivacaftor, is for patients aged 12 and older with certain cystic fibrosis mutations.
February 13, 2018
Gout can be painful and debilitating – but also treatable, explains a new Fast Facts policy brief. A product of the newly formed Alliance for Gout Awareness, the Q&A document aims to inform and empower patients with basic information about the condition.
